Sponsor or institution

Clinical trials and research at Zhongda Hospital

• 21Clinical trials
• 1Country

Newest trials

All recruiting trials (21)

• Lipids, PyroEVs, and PLIN3 in sepsis endothelial injury

  This observational study looks to see if PyroEVs and PLIN3 levels relate to how severe sepsis is and how patients fare.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT07727265

• Epidural spinal cord stimulation to help breathing after cervical spinal cord injury

  This trial tests whether adding epidural spinal cord stimulation to standard care can improve breathing in adults with cervical spinal cord injury and respiratory failure.

  Recruiting at 2 sites Zhongda Hospital · Nanjing, Jiangsu and 1 other locations · NCT07722130

• cfDNA–STING pathway as a marker in atopic dermatitis

  This study will test whether small fragments of DNA in the blood and STING pathway activity in skin match disease severity in adults with atopic dermatitis.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT07573735

• How torso tilt and ventilator PEEP affect lung opening in ARDS

  This study will see if tilting the patient's torso and changing PEEP helps open more lung and improve breathing mechanics in adults with moderate to severe ARDS on a ventilator.

  Recruiting at 2 sites Zhongda Hospital · Nanjing, Jiangsu and 2 other locations · NCT07504731

• Electroacupuncture at Zusanli (ST-36) to help heal diabetic foot ulcers

  This will see if adding electroacupuncture at the Zusanli (ST-36) point to standard wound and diabetes care helps heal diabetic foot ulcers in adults.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT07482137

• Using spectral CT to check tumor response after TACE in hepatocellular carcinoma

  This study tests whether spectral CT can better detect tumor response after TACE in adults with early-to-intermediate hepatocellular carcinoma.

  Recruiting Zhongda Hospital · Nanjing · NCT07351669

• Fasudil plus PD-1 immunotherapy for metastatic castration-resistant prostate cancer

  This Phase 2 trial will test whether adding fasudil hydrochloride to a PD-1 immunotherapy helps men with metastatic castration-resistant prostate cancer who have progressed after docetaxel and novel hormonal therapy.

  Recruiting Phase 2 Zhongda Hospital · Nanjing · NCT07250542

• Homoharringtonine plus hormone therapy before prostate removal for high-risk prostate cancer

  This study tests whether adding homoharringtonine to standard hormone therapy before prostate removal helps men with high-risk, node-positive, or metastatic prostate cancer.

  Recruiting Phase 2 Zhongda Hospital · Nanjing, Jiangsu · NCT07163910

• How frailty before surgery and blood pressure during the operation relate to kidney injury afterward

  This will see if adults judged frail before non-cardiac surgery are more likely to get acute kidney injury after the operation and whether drops in blood pressure during surgery explain that link.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT07030179

• Machine learning prediction of acute kidney injury after non-cardiac surgery

  This project will try a computer-based model to predict which adults are at risk of acute kidney injury after non-cardiac surgery.

  Recruiting Zhongda Hospital · Nanjing · NCT07030166

• Adding periodic 'sigh' breaths to lung-protective ventilation during heart surgery

  This trial will test whether adding periodic deep 'sigh' breaths to low tidal volume, moderate PEEP ventilation reduces early lung complications in adults having elective cardiac surgery with cardiopulmonary bypass.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT07024420

• Comparing two treatments for advanced liver cancer

  This study is testing whether a new treatment using yttrium-90 carbon microspheres works better than the standard chemoembolization for people with advanced liver cancer.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06909708

• Examining the impact of lymph node metastasis on survival in advanced liver cancer

  This study is testing if having cancer spread to lymph nodes affects how long people with advanced liver cancer live after receiving certain treatments.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu and 1 other locations · NCT06876753

• Fasudil plus PD-1 antibody with androgen-deprivation therapy before prostatectomy.

  This trial tests whether adding fasudil and a PD-1 antibody to standard hormone (androgen-deprivation) therapy before prostatectomy helps men with locally advanced or oligometastatic prostate cancer.

  Recruiting Phase 2/3 Zhongda Hospital · Nanjing, Jiangsu · NCT06861192

• Dynamic prediction model for patients with unresectable biliary cancer receiving chemotherapy and immunotherapy

  This study is testing a new way to predict how well patients with advanced bile duct cancer will respond to a combination of chemotherapy and immunotherapy to help doctors decide who can safely start this treatment.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu and 1 other locations · NCT06849193

• Exploring new treatment strategies for patients with unresectable combined liver cancer

  This study is trying to find new treatment options for adults with a type of liver cancer that can't be surgically removed by using advanced technology to better understand their specific cancer subtypes.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06849180

• Neoadjuvant homoharringtonine with hormone therapy before prostatectomy

  This will test whether adding homoharringtonine to standard androgen-deprivation therapy before prostatectomy helps men with locally advanced or oligometastatic prostate cancer.

  Recruiting at 2 sites Phase 2 Zhongda Hospital · Nanjing, Jiangsu and 1 other locations · NCT06834321

• Examining the relationship between Sintilimab levels and treatment outcomes in advanced gastric cancer patients

  This study is testing how the levels of Sintilimab in the blood affect treatment results and side effects for people with advanced gastric cancer.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06702683

• Using radiofrequency ablation to treat liver cancer by targeting sympathetic nerves

  This study is testing a new treatment for advanced liver cancer that combines a special heat procedure with surgery to target nerves, to see if it helps patients who haven't responded to other therapies.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06694636

• Personalized ventilation strategies for patients with acute respiratory distress syndrome

  This study is testing how different breathing support levels and body positions can help improve lung function in patients with severe acute respiratory distress syndrome.

  Recruiting Zhongda Hospital · Nanjing, Jiangsu · NCT06430554

• Comparing two types of microspheres for treating liver cancer

  This study is testing if a new type of microsphere treatment for liver cancer works just as well as a standard treatment to help patients with hepatocellular carcinoma.

  Recruiting at 2 sites Zhongda Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06190665

Quick answers

How many clinical trials run by Zhongda Hospital are recruiting right now?

21, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →